Speaker Profile
M.D., SVP, Eli Lilly & Co
Biography
Mark C. Genovese, MD, is Senior Vice President, Immunology Development at Eli Lilly and Company, where he leads clinical development of Lilly’s mid- and late-stage immunology portfolio. Previously, he was Senior Vice President of Inflammation Development at Gilead Sciences. Before entering industry, he was the James W. Raitt Professor of Medicine and Clinical Chief of Immunology and Rheumatology at Stanford University. His research has focused on translational medicine and clinical trials for autoimmune and rheumatic diseases. He earned his bachelor’s degree from the University of Notre Dame and his MD from Johns Hopkins University School of Medicine, followed by residency and rheumatology fellowship training at Stanford.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Mark Genovese, Eli Lilly
PMWC Award Ceremony
• Miriam Merad, Mount Sinai (Luminary)
• Jeffrey A. Bluestone, UCSF (Luminary)
Featured Speakers
• Miriam Merad, Mount Sinai
• Jeffrey A. Bluestone, UCSF
• Gallia Levy, Gilead
• Marcela V. Maus, Harvard
• Nick Wilson, Biogen
• Megan Levings, BC Children's Hospital Research Institute
• Min Bao, Kali Therapeutics
• Purvesh Khatri, Stanford
• Heleen Scheerens, Genentech
• Pascal Geldsetzer, Stanford
• Dan Littman, NYU
• Anne Kasmar, Parexel
Macrophages Across Inflammation, Cancer & Aging
Master regulators of tissue health and disease across precision immunology.
Immune Reset in Autoimmune Disease
CAR-T, in vivo CAR, and the pursuit of durable remission.
Beyond Broad Immunosuppression
Tolerance, Tregs, and disease-modifying approaches.
Turning Biomarkers on Their Head
What we can measure before we can reliably predict response.
Precision Immunology in Clinical Development
Trial enrichment, deeper endpoints, response prediction, and regulatory strategy.
The Microbial Roots of Autoimmunity
Chronic infection, dysbiosis, and microbial signals shaping disease.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
